** Shares of medical device maker Zimmer Biomet Holdings ZBH.N rise 1.5% to $103.87 premarket
** ZBH posts Q1 adj. profit of $1.81 per share, beating analysts' estimate of $1.77 per share, according to data compiled by LSEG
** Company reports Q1 revenue of $1.91 billion vs estimates of $1.90 billion
** Company cuts its annual adj profit forecast to a range of $7.9 and $8.1 per share, compared with previously projected adj profit forecast of $8.15 to $8.35 per share
** However, ZBH expects 2025 revenue growth to be 5.7% to 8.2% including co's acquisition of orthopedic surgical devices maker Paragon 28 7GQ.F, currency and current tariff impact
** As of last close, ZBH has fallen 3.1% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。